Risk Factors for Pulmonary Hypertension of the Newborn

NCT00005497 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-05-13

No results posted yet for this study

Summary

To conduct a multicenter case-control study of persistent pulmonary hypertension of the newborn (PPHN) in relation to maternal exposure to smoking and non-steroidal anti-inflammatory drugs (NSAIDs). Also, to assess other potential antenatal risk factors and collect and store buccal cell specimens for future analyses.

Conditions

  • Persistent Fetal Circulation Syndrome
  • Lung Diseases

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Allen Mitchell · Boston University

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-04-30
Completion
2004-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005497 on ClinicalTrials.gov